BRANCHINI, Alessio

BRANCHINI, Alessio  

Dipartimento di Scienze della vita e biotecnologie  

Mostra records
Risultati 1 - 20 di 117 (tempo di esecuzione: 0.025 secondi).
Titolo Data di pubblicazione Autore(i) File
A factor X variant with engineered activation peptide as innovative by-passing agent for haemophilia 2022 Tonetto, E.; Tarantino, R.; Testa, M. F.; Peretto, L.; Bernardi, F.; Pinotti, M.; Branchini, A. file con accesso da definire
A new type 1 von Willebrand Disease (VWD) characterized by increased clearance of von Willebrand Factor (VWF) due to the heterozygous p.P1127S mutation: clinical phenotype and pathogenic mechanisms 2022 M. Sacco, M. Tardugno; De Cristofaro, R.; Lancellotti, S.; Bernardi, F.; Pinotti, M.; Branchini, ...A.; Giusti, B.; Castaman, G. file con accesso da definire
A next-generation rFVIIa fusion protein with enhanced half-life as a novel by-passing tool in hemophilia 2020 Branchini, Alessio; Ferrarese, Mattia; Nilsen, Jeannette; Bern, Malin; Davidson, Robert J.; Camir...e, Rodney M.; Roopenian, Derry C.; Sandlie, Inger; Lombardi, Silvia; Terje Andersen, Jan; Pinotti, Mirko
A recoded view on the F9 p.Cys178Ter pathogenic mechanism 2020 Branchini, A.; Pinotti, M.
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B 2018 Pignani, Silvia; Todaro, Alice; Ferrarese, Mattia; Marchi, Saverio; Lombardi, Silvia; Balestra, D...ario; Pinton, Paolo; Bernardi, Francesco; Pinotti, Mirko; Branchini, Alessio
Academic Editor per la rivista PLoS One 2020 Branchini, Alessio file con accesso da definire
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 2016 Martinelli, N; Girelli, D; Baroni, Marcello; Guarini, P; Sandri, M; Lunghi, Barbara; Tosi, F; Bra...nchini, Alessio; Sartori, F; Woodhams, B; Bernardi, Francesco; Olivieri, O.
Activated factor VII: antithrombin complex plasma concentration in subjects with or without angiographically demonstrated coronary artery disease and myocardial infarction 2013 F., Tosi; N., Martinelli; Baroni, Marcello; P., Guarini; S., Udali; Branchini, Alessio; B., Woodh...ams; Bernardi, Francesco; O., Olivieri file con accesso da definire
Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant 2012 Cavallari, Nicola; Balestra, Dario; Branchini, Alessio; Maestri, Iva; Chuamsunrit, A; Sasanakul, ...W; Mariani, G; Pagani, F; Bernardi, Francesco; Pinotti, Mirko file con accesso da definire
Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca 2+ levels and tumor growth 2019 Marchi, Saverio; Corricelli, Mariangela; Branchini, Alessio; Vitto, VERONICA ANGELA MARIA; Missir...oli, Sonia; Morciano, Giampaolo; Perrone, Mariasole; Ferrarese, Mattia; Giorgi, Carlotta; Pinotti, Mirko; Galluzzi, Lorenzo; Kroemer, Guido; Pinton, Paolo
An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A 2019 Balestra, Dario; Maestri, Iva; Branchini, Alessio; Ferrarese, Mattia; Bernardi, Francesco; Pinott...i, Mirko
An engineered factor X variant as a novel by-passing agent for hemophilia 2022 Tonetto, Elena; Testa, Maria Francesca; Tarantino, Rebecca; Peretto, Laura; Pinotti, Mirko; Branc...hini, Alessio file con accesso da definire
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics 2020 Bern, M.; Nilsen, J.; Ferrarese, M.; Sand, K. M. K.; Gjolberg, T. T.; Lode, H. E.; Davidson, R. J....; Camire, R. M.; Baekkevold, E. S.; Foss, S.; Grevys, A.; Dalhus, B.; Wilson, J.; Hoydahl, L. S.; Christianson, G. J.; Roopenian, D. C.; Schlothauer, T.; Michaelsen, T. E.; Moe, M. C.; Lombardi, S.; Pinotti, M.; Sandlie, I.; Branchini, A.; Andersen, J. T.
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 2016 Barbon, Elena; Pignani, Silvia; Branchini, Alessio; Bernardi, Francesco; Pinotti, Mirko; Bovolent...a, Matteo
An exon-specific small nuclear u1 rna (Exspeu1) improves hepatic otc expression in a splicing-defective spf /ash mouse model of ornithine transcarbamylase deficiency 2020 Balestra, D.; Ferrarese, M.; Lombardi, S.; Ziliotto, N.; Branchini, A.; Petersen, N.; Bosma, P.; ...Pinotti, M.; van de Graaf, S. F. J.
An optimized in vitro expression platform identifies Haemophilia B nonsense mutations, and thus patients, eligible for therapeutic drug-induced readthrough 2017 Branchini, Alessio; Ferrarese, Mattia; Castaman, Giancarlo; Bernardi, Francesco; Pinotti, Mirko
Associate Editor per la rivista Frontiers in Genetics - sezione Genetic Disorders 2020 Branchini, Alessio file con accesso da definire
Associate Editor per la rivista Frontiers in Pediatrics - sezione Genetic Disorders 2020 Branchini, Alessio file con accesso da definire
Association of the homozygous nonsense mutation R402X in coagulation factor VII with asymptomatic phenotype 2010 Branchini, Alessio; Rizzotto, Lara; Giansily Blaizot, M.; Canella, Alessandro; Mari, R.; Lapecore...lla, M.; Napolitano, M.; Mariani, G.; Pinotti, Mirko; Bernardi, Francesco file con accesso da definire
Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 2015 Baroni, Marcello; Pavani, Giulia; Pinotti, Mirko; Branchini, Alessio; Bernardi, Francesco; Camire..., R. M.